Results 101 to 110 of about 1,352 (137)

Investigation of the Impact of the H310A FcRn Region Mutation on ⁸⁹Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody. [PDF]

Mol Imaging Biol
Wuensche TE, Stergiou N, Mes I, Verlaan M, Kooijman EJM, Windhorst AD, Jensen A, Asuni AA, Bang-Andersen B, van Dongen GAMS, Vugts DJ, Beaino W.   +11 more
europepmc   +1 more source

Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model [PDF]

, 2019
Agnew, Brian J, Christensen, Camilla, Jensen, Mette M, Kjaer, Andreas, Kristensen, Lotte K, Nielsen, Carsten H, Schjöth-Frydendahl, Christina   +6 more
core   +1 more source

Let’s embrace optical imaging:A growing branch on the clinical molecular imaging tree [PDF]

, 2021
Dierckx, Rudi A.J.O., Kruijff, Schelto, Nagengast, Wouter B., Noltes, Milou E., Slart, Riemer H.J.A., Szymanski, Wiktor, van Dam, Gooitzen M., van der Zaag, Pieter J.   +7 more
core   +1 more source

Interobserver reproducibility of tumor uptake quantification with ⁸⁹Zr-immuno-PET: a multicenter analysis. [PDF]

Eur J Nucl Med Mol Imaging, 2019
Jauw YWS, Bensch F, Brouwers AH, Hoekstra OS, Zijlstra JM, Pieplenbosch S, Schröder CP, Zweegman S, van Dongen GAMS, Menke-van der Houven van Oordt CW, de Vries EGE, de Vet HCW, Boellaard R, Huisman MC.   +13 more
europepmc   +1 more source

89Zr-immuno-PET:Towards a clinical tool to guide antibody-based therapy in cancer [PDF]

, 2019
Jauw, Y.W.S.
core  

Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET. [PDF]

J Nucl Med, 2014
Doran MG, Watson PA, Cheal SM, Spratt DE, Wongvipat J, Steckler JM, Carrasquillo JA, Evans MJ, Lewis JS.   +8 more
europepmc   +1 more source

Development of Zr-89-Ontuxizumab for in vivo TEM-1/endosialin PET applications [PDF]

, 2016
Lange, Sara E. S., Lapi, Suzanne E., O\u27Shannessy, Daniel J., Studer, Matthew, Van Tine, Brian A., Zheleznyak, Alex   +5 more
core   +1 more source

Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti-Amyloid-β Antibody. [PDF]

J Nucl Med
Lopes van den Broek S, Bratteby K, Aguilar X, Tran TA, Syvänen S, Sehlin D.   +5 more
europepmc   +1 more source

Tetraspanin-8 as a Tumor-Selective Immuno-PET Target in Hepatocellular Carcinoma. [PDF]

J Nucl Med
Sheehan-Klenk J, Makala H, Chung JY, Lee W, Baidoo KE, Nambiar D, Alani N, Hewitt SM, Ueda Y, Omiya S, Escorcia FE.   +10 more
europepmc   +1 more source

Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis. [PDF]

J Nucl Med, 2016
Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS.   +8 more
europepmc   +1 more source